CMTTdb

An integrated database for cancer molecular targeted thearpies

View Agent


Agent Info
Agent:neratinib
Synonyms:NA
Drug Status For Certain Diseases:Lymphoma(phase III)
Classification:2nd-generation,reversible pan-EGFR family tyrosine kinase inhibitor(dual EGFR/human epidermal growth factor receptor 2 TKIs )
Target:mRNA of human epidermal growth factor receptor 2
Vascular endothelial growth factor receptor 2
Epidermal growth factor receptor
KEGG Pathway:Ras signaling pathway
non-small-cell lung cancer
Endometrial cancer
Pancreatic cancer
Adherens junction
ErbB signaling pathway
VEGF signaling pathway
Rap1 signaling pathway
Pathways in cancer
Central carbon metabolism in cancer
PI3K-Akt signaling pathway
Prostate cancer
MicroRNAs in cancer
Endocytosis
Bladder cancer
Wiki Pathway:EGF/EGFR Signaling Pathway
L1CAM interactions
Hair Follicle Development
Spinal Cord Injury
Gastric cancer network 2
miR-targeted genes in epithelium - TarBase
MAPK Signaling Pathway
TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer
ErbB Signaling Pathway
Signaling by ERBB2
Signaling by ERBB4
miR-targeted genes in lymphocytes - TarBase
DNA Damage Response (only ATM dependent)
Integrated Pancreatic Cancer Pathway
Leptin signaling pathway
Focal Adhesion
Aryl Hydrocarbon Receptor Pathway
Aryl Hydrocarbon Receptor
Signaling by EGFR
Nifedipine Activity
Regulation of Actin Cytoskeleton
PIP3 activates AKT signaling
Nanoparticle-mediated activation of receptor signaling
Arylhydrocarbon receptor (AhR) signaling pathway
Extracellular vesicle-mediated signaling in recipient cells
Bladder Cancer
miR-targeted genes in muscle cell - TarBase
Signaling by VEGF
Gastrin-CREB signalling pathway via PKC and MAPK
Integrated Breast Cancer Pathway
Signaling Pathways in Glioblastoma
Semaphorin interactions
Cardiac Progenitor Differentiation
Hair Follicle Development
AGE/RAGE pathway
Angiogenesis